Baseline lesion. Ebstein anomaly results from failed delamination of the septal and inferior tricuspid leaflets with apical displacement of the hinge line, atrialization of the proximal RV, and a diminutive, often myopathic functional RV. Severe TR and a right-to-left interatrial shunt (PFO/ASD) are common features [1, 2]. PubMed+1
Immediate postnatal state (high PVR, limited RV→PA flow). In the first hours of life, physiologically high PVR imposes a large afterload on the small, inefficient RV. Combined with severe TR, this yields poor antegrade pulmonary flow and elevated RA pressure; in the absence of a ductal pathway, pulmonary blood flow depends entirely on what the RV can deliver. The interatrial pressure gradient therefore favors R→L shunting with systemic desaturation and cyanosis [1, 3]. PubMed+1
Evolution as PVR falls. Over days, falling PVR can unmask or restore RV→PA forward flow—provided the pulmonary valve is anatomically permissive and the functional RV has sufficient contractile reserve. In a comparative series of neonates with no initial RV forward flow, those with a normal pulmonary valve (larger annulus) typically established antegrade flow around ~10 days and more often achieved bi- or 1½-ventricle circulation than those with abnormal valves [4]. PubMed
Determinants of trajectory.
- RV performance/TR severity. The balance between RV systolic capacity and TR governs whether the fall in PVR translates into meaningful forward flow [1, 2]. PubMed+1
- Pulmonary valve morphology and annulus size. A normal valve/large annulus predicts recovery of antegrade flow and better survival [4]. PubMed
- Interatrial communication. A large, nonrestrictive PFO/ASD decompresses the RA but sustains hypoxemia; a restrictive septum risks inadequate LV preload and low output [1]. PubMed
- Pulmonary vascular tone. Hypoxia, acidosis, and agitation raise PVR and worsen the physiology; gentle ventilation, adequate oxygenation, and normothermia lower PVR and support transition [1]. PubMed
Functional pulmonary atresia. When PVR is high and RV systolic pressure is low, the effective physiology may mimic pulmonary atresia despite a patent valve—functional pulmonary atresia—which can reverse as PVR falls and RV performance improves [1, 5]. PubMed+1
Hemodynamics and imaging. Expect markedly elevated RA pressure, reduced Qp:Qs, and systemic output that relies on interatrial mixing for LV preload. Echocardiography typically shows a massively dilated RA, atrialized RV, a small functional RV with low stroke volume, severe TR, and little or no antegrade PA color-Doppler signal while PVR remains high [1]. PubMed
Management implications (principles for the “no-PDA” neonate).
- Prostaglandin E1 does not improve pulmonary blood flow when no ductal pathway exists; focus instead on lowering PVR (oxygenation, normocapnia/mild alkalosis, sedation, normothermia) and optimizing RV preload/contractility while maintaining sinus rhythm [1, 3]. PubMed+1
- Serial reassessment during the natural PVR decline is essential; if RV→PA flow emerges (often within ~1–2 weeks in those with a normal PV), progressive improvement in oxygenation follows [4]. PubMed
- Interatrial septum management. If LV preload is limited by a restrictive atrial septum with low systemic output, relief (e.g., balloon atrial septostomy) can be lifesaving; conversely, once stable antegrade flow is established, a large ASD may perpetuate desaturation and later warrant closure [1]. PubMed
- Escalation and surgical pathways. When transition fails—e.g., persistent functional atresia, torrential TR with severe RV dysfunction—care is individualized. Options range from temporizing strategies to definitive neonatal surgery; contemporary reviews emphasize tailoring intervention to anatomy + physiology along the spectrum from biventricular repair to single-ventricle–leaning approaches [3, 6]. PubMed+1
References
[1] Kumar TKS. Ebstein's anomaly in the neonate. Indian J Thorac Cardiovasc Surg. 2021;37(Suppl 1):17-25. doi:10.1007/s12055-020-00942-z. PubMed
[2] Wackel PL, Dearani JA, Cetta F. Neonatal Ebstein repair—where are we now? Ann Transl Med. 2017;5(5):109. doi:10.21037/atm.2017.01.19. PubMed
[3] Jaquiss RDB, Imamura M. Management of Ebstein’s anomaly and pure tricuspid insufficiency in the neonate. Semin Thorac Cardiovasc Surg. 2007;19(3):258-263. doi:10.1053/j.semtcvs.2007.07.004. PubMed
[4] Baek JS, Yu JJ, Im YM, Yun T-J. Outcomes of neonatal Ebstein’s anomaly without right ventricular forward flow. J Thorac Cardiovasc Surg. 2016;152(2):516-521. doi:10.1016/j.jtcvs.2016.03.084. PubMed
[5] Azeka E, et al. Functional atresia of the pulmonary valve in neonates with Ebstein’s anomaly. Arq Bras Cardiol. 1992;59(4):217-220. (PubMed PMID: 1307457). PubMed
[6] Sainathan S, Tang GH, Andrianopoulos N. Ebstein’s anomaly: contemporary management strategies. Ann Cardiothorac Surg. 2020;9(3):229-239. PMC